Saturna Capital Corp Boosts Position in Colgate-Palmolive (NYSE:CL)

Saturna Capital Corp grew its stake in Colgate-Palmolive (NYSE:CL) by 0.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 490,200 shares of the company’s stock after acquiring an additional 1,000 shares during the period. Saturna Capital Corp’s holdings in Colgate-Palmolive were worth $44,564,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Kohmann Bosshard Financial Services LLC bought a new stake in shares of Colgate-Palmolive in the 4th quarter valued at about $26,000. Centricity Wealth Management LLC bought a new stake in Colgate-Palmolive during the fourth quarter valued at about $27,000. Union Bancaire Privee UBP SA purchased a new position in Colgate-Palmolive in the fourth quarter valued at about $32,000. Briaud Financial Planning Inc bought a new position in Colgate-Palmolive in the fourth quarter worth about $32,000. Finally, OFI Invest Asset Management bought a new stake in shares of Colgate-Palmolive in the 4th quarter valued at about $36,000. 80.41% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on CL. Wells Fargo & Company decreased their target price on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research report on Tuesday, January 7th. UBS Group decreased their price objective on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a report on Monday, February 3rd. Morgan Stanley dropped their target price on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a research note on Monday, February 3rd. StockNews.com raised Colgate-Palmolive from a “hold” rating to a “buy” rating in a research report on Monday, March 3rd. Finally, TD Cowen lowered their price target on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a report on Wednesday, January 8th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Colgate-Palmolive has an average rating of “Moderate Buy” and a consensus price target of $101.61.

Colgate-Palmolive Stock Down 3.5 %

CL stock opened at $94.05 on Wednesday. The firm’s fifty day moving average is $89.03 and its 200 day moving average is $94.99. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92. Colgate-Palmolive has a one year low of $85.32 and a one year high of $109.30. The firm has a market cap of $76.32 billion, a PE ratio of 26.72, a P/E/G ratio of 4.20 and a beta of 0.40.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period last year, the firm posted $0.87 earnings per share. On average, research analysts forecast that Colgate-Palmolive will post 3.75 EPS for the current year.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.